Panax ginseng shows highest effectiveness in treating Alzheimer's. Learn more about AVXL's blarcamesine and SAVA's simufilam ...
About Anavex Life Sciences Corp.
Cantor Fitzgerald has recently reduced Anavex Life Sciences Corp (AVXL) stock to Neutral rating, as announced on December 6, 2022, according to Finviz. Earlier, on June 23, 2022, Berenberg had ...
On Friday, Anavex Life Sciences Corp (AVXL) stock saw a modest uptick, ending the day at $9.24 which represents a slight increase of $1.60 or 20.94% from the prior close of $7.64. The stock opened at ...
The stock is currently trading at just under $27. AVXL: Anavex Life Sciences rounds out the list as another heavily-shorted ...